Depletion of Hepatic Macrophages Aggravates Liver Lesions Induced in Rats by Thioacetamide (TAA)

Toxicologic Pathology

Volumn 44, Issue 2, 2016, Pages 246-258

  Golbar, Hossain M ^a   Izawa, Takeshi ^a   Wijesundera, Kavindra K ^a   Bondoc, Alexandra ^a   Tennakoon, Anusha H ^a   Kuwamura, Mitsuru ^a   Yamate, Jyoji ^a  

^a Osaka Prefecture University   (Japan)

Author keywords

clodronate; coagulation necrosis; fibrosis; liver; macrophage; thioacetamide

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CD163 ANTIGEN; CLODRONIC ACID; GELATINASE A; MESSENGER RNA; THIOACETAMIDE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CALCINOSIS; FIBROSIS; HISTOCOMPATIBILITY COMPLEX; HISTOPATHOLOGY; IMMUNITY; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; KUPFFER CELL; LIVER CELL; LIVER INJURY; LIVER PARENCHYMA; LIVER TOXICITY; MACROPHAGE; MALE; MESENCHYME CELL; MYOFIBROBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; TISSUE INJURY; ANIMAL; CHEMISTRY; CYTOLOGY; FISCHER 344 RAT; LIVER; METABOLISM; NECROSIS; PATHOLOGY; TOXIC HEPATITIS;

ANIMALS; CHEMICAL AND DRUG INDUCED LIVER INJURY; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; LIVER; MACROPHAGES; MALE; MYOFIBROBLASTS; NECROSIS; RATS; RATS, INBRED F344; THIOACETAMIDE;

EID: 84960390160     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623315621191     Document Type: Article

References (42)

1. Bataller R., Brenner D. A., (2005). Liver fibrosis. J Clin Invest 115, 209-18.
2. Beatty G. L., Chiorean E. G., Fishman M. P., Saboury B., Teitelbaum U. R., Sun W., Huhn R. D., Song W., Li D., Sharp L. L., Torigian D. A., O'Dwyer P. J., Vonderheide R. H., (2011). CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 331, 1612-16.
3. Beljaars L., Schippers M., Reker-Smit C., Martinez F. O., Helming L., Poelstra K., Melgert B. N., (2014). Hepatic localization of macrophage phenotypes during fibrogenesis and resolution of fibrosis in mice and humans. Front Immunol 5, 430.
4. Conrad A. T., Dittel B. N., (2011). Taming of macrophage and microglial cell activation by microRNA-124. Cell Res 21, 213-16.
5. Damoiseaux J. G., Döpp E. A., Calame W., Chao D., MacPherson G. G., Dijkstra C. D., (1994). Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 83, 140-47.
6. Duffield J. S., Forbes S. J., Constandinou C. M., Clay S., Partolina M., Vuthoori S., Wu S., Lang R., Iredale J. P., (2005). Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115, 56-65.
7. Fujiwara N., Kobayashi K., (2005). Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 4, 281-86.
8. Golbar H. M., Izawa T., Ichikawa C., Tanaka M., Juniantito V., Sawamoto O., Kuwamura M., Yamate J., (2013a). Slowly progressive cholangiofibrosis induced in rats by α-naphthylisothiocyanate (ANIT), with particular references to characteristics of macrophages and myofibroblasts. Exp Toxicol Pathol 65, 825-35.
9. Golbar H. M., Izawa T., Juniantito V., Ichikawa C., Tanaka M., Kuwamura M., Yamate J., (2013b). Immunohistochemical characterization of macrophages and myofibroblasts in fibrotic liver lesions due to Fasciola infection in cattle. J Vet Med Sci 75, 857-65.
10. Golbar H. M., Izawa T., Murai F., Kuwamura M., Yamate J., (2012). Immunohistochemical analyses of the kinetics and distribution of macrophages, hepatic stellate cells and bile duct epithelia in the developing rat liver. Exp Toxicol Pathol 64, 1-8.
11. Golbar H. M., Izawa T., Yano R., Ichikawa C., Sawamoto O., Kuwamura M., LaMarre J., Yamate J., (2011). Immunohistochemical characterization of macrophages and myofibroblasts in α-naphthylisothiocyanate (ANIT)-induced bile duct injury and subsequent fibrogenesis in rats. Toxicol Pathol 39, 795-808.
12. Henderson N. C., Forbes S. J., (2008). Hepatic fibrogenesis: From within and outwith. Toxicology 254, 130-35.
13. Kiyanagi T., Iwabuchi K., Shimada K., Hirose K., Miyazaki T., Sumiyoshi K., Iwahara C., Nakayama H., Masuda H., Mokuno H., Sato S., Daida H., (2011). Involvement of cholesterol-enriched microdomains in class A scavenger receptor-mediated responses in human macrophages. Atherosclerosis 215, 60-69.
14. La Flamme A. C., Kharkrang M., Stone S., Mirmoeini S., Chuluundorj D., Kyle R., (2012). Type II-activated murine macrophages produce IL-4. PLoS One 7, e46989.
15. Laskin D. L., Sunil V. R., Gardner C. R., Laskin J. D., (2011). Macrophages and tissue injury: Agents of defense or destruction? Annu Rev Pharmacol Toxicol 51, 267-88.
16. Lech M., Anders H., (2013). Macrophages and fibrosis: How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair. Biochim Biophys Acta 1832, 989-97.
17. Mantovani A., Sozzani S., Locati M., Allavena P., Antonio S., (2002). Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23, 549-55.
18. Martinez F. O., (2011). Regulators of macrophage activation. Eur J Immunol 41, 1531-34.
19. Martinez F. O., Gordon S., (2014). The M1 and M2 paradigm of macrophage activation: Time for reassessment. F1000Prime Reports 6, 13.
20. Martinez F. O., Sica A., Mantovani A., Locati M., (2008). Macrophage activation and polarization. Front Biosci 13, 453-61.
21. McGuinness P. H., Painter D., Davies S., McGaughan G. W., (2000). Increases in intrahepatic CD68 positive cells. MAC387 positive cells and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut 46, 260-69.
22. Mori Y., Izawa T., Takenaka S., Kuwamura M., Yamate J., (2009). Participation of functionally different macrophage populations and monocyte chemoattractant protein-1 in early stages of thioacetamide-induced rat hepatic injury. Toxicol Pathol 37, 463-73.
23. Novak M. L., Koh T. J., (2013). Macrophage phenotypes during tissue repair. J Leukoc Biol 93, 875-81.
24. Ong C. B., Brandenberger C., Kiupel M., Kariagina A., Langohr I. M., (2015). Immunohistochemical characterization and morphometric analysis of macrophages in rat mammary tumors. Vet Pathol 52, 414-18.
25. Pellicoro A., Ramachandran P., Iredale J. P., Fallowfield J. A., (2014). Liver fibrosis and repair: Immune regulation of wound healing in a solid organ. Nat Rev Immunol 14, 181-94.
26. Polfliet M. M., Fabriek B. O., Daniëls W. P., Dijkstra C. D., van den Berg T. K., (2006). The rat macrophage scavenger receptor CD163: Expression, regulation and role in inflammatory mediator production. Immunobiology 211, 419-25.
27. Radi Z. A., Koza-Taylor P. H., Bell R. R., Obert L. A., Runnels H. A., Beebe J. S., Lawton M. P., Sadis S., (2011). Increased serum enzyme levels associated with kupffer cell reduction with no signs of hepatic or skeletal muscle injury. Am J Pathol 179, 240-47.
28. Schümann J., Wolf D., Pahl A., Brune K., Papadopoulos T., van Rooijen N., Tiegs G., (2000). Importance of Kupffer cells for T-cell dependent liver injury in mice. Am J Pathol 157, 1671-83.
29. Sica A., Mantovani A., (2012). Macrophage plasticity and polarization: In vivo veritas. J Clin Invest 122, 787-95.
30. Sindrilaru A., Scharffetter-Kochanek K., (2013). Disclosure of the culprits: Macrophages-Versatile regulators of wound healing. Adv Wound Care (New Rochelle) 2, 357-68.
31. Smit M. J., Duursma A. M., Joop M., Bouma W., Gruber J. M., (1987). Receptor-mediated endocytosis of lactate dehydrogenase M, by liver macrophages: A mechanism for elimination of enzymes from plasma. J Biol Chem 262, 13020-26.
32. Soehnlein O., Lindbom L., (2010). Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 10, 427-39.
33. Tacke F., Zimmermann H. W., (2014). Macrophage heterogeneity in liver injury and fibrosis. J Hepatol 60, 1090-96.
34. van Rooijen N., Sanders A., (1994). Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications. J Immunol Methods 174, 83-93.
35. van Rooijen N., Hendrikx E., (2010). Liposomes for specific depletion of macrophages from organs and tissues. Methods Mol Biol 605, 189-203.
36. Wijesundera K. K., Izawa T., Murakami H., Tennakoon A. H., Golbar H. M., Kato-Ichikawa C., Tanaka M., Kuwamura M., Yamate J., (2014). M1- and M2-macrophage polarization in thioacetamide (TAA)-induced rat liver lesions; a possible analysis for hepato-pathology. Histol Histopathol 29, 497-511.
37. Wynn T. A., (2008). Cellular and molecular mechanisms of fibrosis. J Pathol 214, 199-210.
38. Wynn T. A., Barron L., (2010). Macrophages: Master regulators of inflammation and fibrosis. Semin Liver Dis 30, 245-57.
39. Xu J., Xiao X., Koyama Y., Wang P., Lan T., Kim I., Kim I. H., Ma H., Kisseleva T., (2014). The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies. Front Pharmacol 5, 167.
40. Yamate J., Ishimine S., Izawa T., Kumagai D., Kuwamura M., (2009). Macrophage populations and expressions of regulatory proinflammatory factors in the rat meninx under lipopolysaccharide treatment in vivo and in vitro. Histol Histopathol 24, 13-24.
41. Yamate J., Yoshida H., Tsukamoto Y., Ide M., Kuwamura M., Ohashi F., Miyamoto T., Kotani T., Sakuma S., Takeya M., (2000). Distribution of cells immunopositive for AM-3K, a novel monoclonal antibody recognizing human macrophages, in normal and diseased tissues of dogs, cats, horses, cattle, pigs, and rabbits. Vet Pathol 37, 168-76.
42. Zizzo G., Hilliard B. A., Monestier M., Cohen P. L., (2012). Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol 189, 3508-20.